Experimental design. by Shane R. McClafferty (19434460)

Training and validation accuracy and losses for 5-stage classification. by Salih Furkan Atici (12988243)

Grooming in isolation. by Shane R. McClafferty (19434460)

Linkage disequilibrium of the SNPs in the APOA1/C3/A4/A5 gene cluster. by Yanhua Wu (141984)

DnaK inhibits protein synthesis in vivo and in vitro. by Carissa Chan (18310140)

Contact tracing efficiency needed to avoid overwhelming contact tracing capacity, as a function of the proportion of immune individuals in a population and for different contact ra... by Maria M. Martignoni (8563158)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

ND5 mutant mitochondria have a reduced ability to buffer calcium. by Matthew McKenzie (849898)

“…Increases in [Ca²⁺] up to 2.48 μM were buffered by CON cybrid mitochondria, with a step-wise decrease (followed by recovery) of Δψ_m evident. …”

Linearity of the Panther Fusion^® SARS-CoV-2 assay for pooled testing. by Rudolph Park (14070418)

Effect of NAT1 knockout on cell growth in normal and low glucose. by LiLi Wang (1582915)

Fig 2 - by Oliver Campbell (17283127)

DDX5 and DDX17 are required for KSHV lytic reactivation. by Praneet Kaur Sandhu (21156149)

Data of research. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Sample characterization (n = 30). by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Flowchart of sample eligibility. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

“…</p><p>Methods</p><p>This was a prospective cohort study involving children aged 5–15 years with myopia who were treated with 0.125% atropine for myopia control. …”

Serotonin modulates L2 neuron visually induced calcium transient kinetics. by Maureen M. Sampson (9322886)

“…Recordings in B-E represent, N = 14 and N = 20 individual flies perfused with serotonin or saline respectively. Shaded areas show mean +/- SEM. Comparisons are two-way repeated measures ANOVA with the bracket in 5C’ indicating a significant effect of genotype (p≤0.05*).…”

Bar chart representing the binding intensity of His-tagged recombinant SARS-CoV-2 protein antigens to printed serum antibody isotypes purified from one SARS-CoV-2-positive patient... by Marie Le Berre (6299012)

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i>^<i>2</i> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i>^<i>2</i> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i>^<i>2</i> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i>^<i>2</i> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i>^<i>2</i> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i>^<i>2</i> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”